OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients
Sunee Sirivichayakul, Buranee Kanchanatawan, Supaksorn Thika, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 1, pp. 122-138
Closed Access | Times Cited: 77
Sunee Sirivichayakul, Buranee Kanchanatawan, Supaksorn Thika, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 1, pp. 122-138
Closed Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
Chutima Roomruangwong, Cristiano Noto, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 778-797
Closed Access | Times Cited: 138
Chutima Roomruangwong, Cristiano Noto, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 778-797
Closed Access | Times Cited: 138
Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Neurotoxicity Research (2019) Vol. 36, Iss. 2, pp. 306-322
Closed Access | Times Cited: 88
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Neurotoxicity Research (2019) Vol. 36, Iss. 2, pp. 306-322
Closed Access | Times Cited: 88
CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders
Mariya Ivanovska, Zakee Abdi, Marianna Murdjeva, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 230-230
Open Access | Times Cited: 73
Mariya Ivanovska, Zakee Abdi, Marianna Murdjeva, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 230-230
Open Access | Times Cited: 73
Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications
Donya Nazarinia, Mahin Behzadifard, Javad Gholampour, et al.
Acta Neurologica Belgica (2022) Vol. 122, Iss. 4, pp. 865-869
Open Access | Times Cited: 49
Donya Nazarinia, Mahin Behzadifard, Javad Gholampour, et al.
Acta Neurologica Belgica (2022) Vol. 122, Iss. 4, pp. 865-869
Open Access | Times Cited: 49
In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype
Michaël Maes, Buranee Kanchanatawan, Sunee Sirivichayakul, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 3, pp. 684-698
Closed Access | Times Cited: 65
Michaël Maes, Buranee Kanchanatawan, Sunee Sirivichayakul, et al.
Neurotoxicity Research (2018) Vol. 35, Iss. 3, pp. 684-698
Closed Access | Times Cited: 65
Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4578-4597
Closed Access | Times Cited: 58
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4578-4597
Closed Access | Times Cited: 58
Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7056-7073
Closed Access | Times Cited: 55
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7056-7073
Closed Access | Times Cited: 55
High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 530-541
Open Access | Times Cited: 53
Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 530-541
Open Access | Times Cited: 53
Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia
Michaël Maes, Aristo Vojdani, Sunee Sirivichayakul, et al.
Molecular Neurobiology (2021)
Closed Access | Times Cited: 47
Michaël Maes, Aristo Vojdani, Sunee Sirivichayakul, et al.
Molecular Neurobiology (2021)
Closed Access | Times Cited: 47
The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines
Tomasz Boczek, Joanna Mackiewicz, Marta Sobolczyk, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1228-1228
Open Access | Times Cited: 44
Tomasz Boczek, Joanna Mackiewicz, Marta Sobolczyk, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1228-1228
Open Access | Times Cited: 44
Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 5, pp. 2333-2345
Closed Access | Times Cited: 50
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 5, pp. 2333-2345
Closed Access | Times Cited: 50
A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions
Sunee Sirivichayakul, Buranee Kanchanatawan, Supaksorn Thika, et al.
CNS & Neurological Disorders - Drug Targets (2018) Vol. 18, Iss. 2, pp. 124-140
Closed Access | Times Cited: 49
Sunee Sirivichayakul, Buranee Kanchanatawan, Supaksorn Thika, et al.
CNS & Neurological Disorders - Drug Targets (2018) Vol. 18, Iss. 2, pp. 124-140
Closed Access | Times Cited: 49
The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study
Hussein Kadhem Al‐Hakeim, Abbas F. Almulla, Michaël Maes
Neurotoxicity Research (2020) Vol. 37, Iss. 3, pp. 753-771
Closed Access | Times Cited: 40
Hussein Kadhem Al‐Hakeim, Abbas F. Almulla, Michaël Maes
Neurotoxicity Research (2020) Vol. 37, Iss. 3, pp. 753-771
Closed Access | Times Cited: 40
Microglial Inflammatory Responses to SARS‐CoV‐2 Infection: A Comprehensive Review
Rajen Dey, Biswadev Bishayi
Cellular and Molecular Neurobiology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 14
Rajen Dey, Biswadev Bishayi
Cellular and Molecular Neurobiology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 14
The Gold Standard Diagnosis of Schizophrenia is Counterproductive: Towards Quantitative Research and Diagnostic Algorithmic Rules (RADAR) and their Derived Qualitative Distinct Classes
Michaël Maes
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 20, pp. 1799-1815
Open Access | Times Cited: 5
Michaël Maes
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 20, pp. 1799-1815
Open Access | Times Cited: 5
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients
Dawn Matthews, Jefferson W. Kinney, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Dawn Matthews, Jefferson W. Kinney, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia
Buranee Kanchanatawan, Sira Sriswasdi, Michaël Maes
Metabolic Brain Disease (2018) Vol. 34, Iss. 1, pp. 267-282
Open Access | Times Cited: 45
Buranee Kanchanatawan, Sira Sriswasdi, Michaël Maes
Metabolic Brain Disease (2018) Vol. 34, Iss. 1, pp. 267-282
Open Access | Times Cited: 45
Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia
Abbas F. Almulla, Hussein Kadhem Al‐Hakeim, Michaël Maes
CNS Spectrums (2020) Vol. 26, Iss. 4, pp. 368-377
Open Access | Times Cited: 39
Abbas F. Almulla, Hussein Kadhem Al‐Hakeim, Michaël Maes
CNS Spectrums (2020) Vol. 26, Iss. 4, pp. 368-377
Open Access | Times Cited: 39
Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia
Mei Hong Xiu, Dongmei Wang, Xiang Dong Du, et al.
Psychoneuroendocrinology (2019) Vol. 108, pp. 110-117
Closed Access | Times Cited: 36
Mei Hong Xiu, Dongmei Wang, Xiang Dong Du, et al.
Psychoneuroendocrinology (2019) Vol. 108, pp. 110-117
Closed Access | Times Cited: 36
Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
Hussein Kadhem Al‐Hakeim, Abbas F. Almulla, Arafat Hussein Al-Dujaili, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 9, pp. 747-758
Closed Access | Times Cited: 33
Hussein Kadhem Al‐Hakeim, Abbas F. Almulla, Arafat Hussein Al-Dujaili, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 9, pp. 747-758
Closed Access | Times Cited: 33
In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life
Michaël Maes, Buranee Kanchanatawan
CNS Spectrums (2021), pp. 1-10
Open Access | Times Cited: 28
Michaël Maes, Buranee Kanchanatawan
CNS Spectrums (2021), pp. 1-10
Open Access | Times Cited: 28
Major neurocognitive psychosis: a novel schizophrenia endophenotype class that is based on machine learning and resembles Kraepelin’s and Bleuler’s conceptions
Michaël Maes
Acta Neuropsychiatrica (2022) Vol. 35, Iss. 3, pp. 123-137
Open Access | Times Cited: 19
Michaël Maes
Acta Neuropsychiatrica (2022) Vol. 35, Iss. 3, pp. 123-137
Open Access | Times Cited: 19
Alterations in fecal microbiota composition and cytokine expression profiles in adolescents with depression: a case-control study
Yiwen Cheng, Zhangcheng Zhu, Zhi Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yiwen Cheng, Zhangcheng Zhu, Zhi Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome
Michaël Maes, Buranee Kanchanatawan, Sunee Sirivichayakul, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 5122-5135
Closed Access | Times Cited: 34
Michaël Maes, Buranee Kanchanatawan, Sunee Sirivichayakul, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 5122-5135
Closed Access | Times Cited: 34
In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
The World Journal of Biological Psychiatry (2020) Vol. 21, Iss. 5, pp. 383-401
Closed Access | Times Cited: 29
Michaël Maes, Sunee Sirivichayakul, Buranee Kanchanatawan, et al.
The World Journal of Biological Psychiatry (2020) Vol. 21, Iss. 5, pp. 383-401
Closed Access | Times Cited: 29
